EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia

Toshihiro Sato iD, Takeshi Kawabata iD, Masaki Kumondai iD, Nagomi Hayashi, Hiroshi Komatsu iD, Yuki Kikuchi iD, Go Onoguchi, Yu Sato iD, Kei Nanatani iD, Masahiro Hiratsuka iD, Masamitsu Maekawa iD, Hiroaki Yamaguchi iD und 3 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252313228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Toshihiro Sato und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan. Hauptthemen laut MEDLINE: Clozapine, Polymorphism, Single Nucleotide, Liver-Specific Organic Anion Transporter 1, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital, Research grant from Japan Research Foundation for Clinical Pharmacology, Japan Research Foundation for Clinical Pharmacology, Tokyo, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The involvement of drug-metabolizing enzymes and transporters in plasma clozapine (CLZ) dynamics has not been well examined in Japanese patients with treatment-resistant schizophrenia (TRS). Therefore, this clinical study investigated the relationship between single nucleotide polymorphisms (SNPs) of various pharmacokinetic factors (drug-metabolizing enzymes and transporters) and dynamic changes in CLZ. Additionally, we aimed to determine whether CLZ acts as a substrate for pharmacokinetic factors using in vitro assays and molecular docking calculations. We found that 6 out of 10 patients with TRS and with multiple organic anion transporting polypeptide (OATP) variants (OATP1B1: *1b, *15; OATP1B3: 334T>G, 699G>A; and OATP2B1: *3, 935G>A, 601G>A, 76_84del) seemed to be highly exposed to CLZ and/or N-desmethyl CLZ. A CLZ uptake study using OATP-expressing HEK293 cells showed that CLZ was a substrate of OATP1B1 with Km and Vmax values of 38.9 µM and 2752 pmol/mg protein/10 min, respectively. The results of molecular docking calculations supported the differences in CLZ uptake among OATP molecules and the weak inhibitory effect of cyclosporine A, which is a strong inhibitor of OATPs, on CLZ uptake via OATP1B1. This is the first study to show that CLZ is an OATP1B1 substrate and that the presence of SNPs in OATPs potentially alters CLZ pharmacokinetic parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapinePolymorphism, Single NucleotideLiver-Specific Organic Anion Transporter 1Molecular Docking SimulationHumansMaleAdultFemaleHEK293 CellsMiddle AgedSchizophrenia, Treatment-ResistantAntipsychotic AgentsSchizophreniaOrganic Anion Transporters

Stichwörter der Autor:innen

JapaneseOATP1B1SNPclozapinenorclozapinetreatment-resistant schizophrenia

Substanzen

ClozapineLiver-Specific Organic Anion Transporter 1SLCO1B1 protein, humanAntipsychotic AgentsOrganic Anion Transporters

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan.
  • Graduate School of Information Sciences, Tohoku University, Sendai 980-8578, Japan.
  • Faculty of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
  • Department of Psychiatry, Tohoku University Hospital, Sendai 980-8574, Japan.
  • Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.
  • Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai 980-8573, Japan.

ORCID-Profile: Toshihiro Sato, Takeshi Kawabata, Masaki Kumondai, Hiroshi Komatsu, Yuki Kikuchi, Yu Sato, Kei Nanatani, Masahiro Hiratsuka, Masamitsu Maekawa, Hiroaki Yamaguchi, Hiroaki Tomita

Förderung

  • The Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital
  • Research grant from Japan Research Foundation for Clinical Pharmacology
  • Japan Research Foundation for Clinical Pharmacology, Tokyo, Japan

Zitieren

APA

Sato, T., Kawabata, T., Kumondai, M., Hayashi, N., Komatsu, H., Kikuchi, Y., Onoguchi, G., Sato, Y., Nanatani, K., Hiratsuka, M., Maekawa, M., Yamaguchi, H., Abe, T., Tomita, H., & Mano, N. (2024). Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313228

Vancouver

Sato T, Kawabata T, Kumondai M, Hayashi N, Komatsu H, Kikuchi Y, et al. Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313228

BibTeX
@article{Sato2024,
  author = {Sato, Toshihiro and Kawabata, Takeshi and Kumondai, Masaki and Hayashi, Nagomi and Komatsu, Hiroshi and Kikuchi, Yuki and Onoguchi, Go and Sato, Yu and Nanatani, Kei and Hiratsuka, Masahiro and Maekawa, Masamitsu and Yamaguchi, Hiroaki and Abe, Takaaki and Tomita, Hiroaki and Mano, Nariyasu},
  title = {Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252313228}
}
Kostenlos starten →